MiniMed Group, Inc. (MMED)
19.18
-0.76
(-3.81%)
USD |
NASDAQ |
Aug 25, 12:39
MiniMed Group Enterprise Value : 5.355B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 5.355B |
| August 21, 2026 | 5.498B |
| August 20, 2026 | 5.422B |
| August 19, 2026 | 5.433B |
| August 18, 2026 | 5.192B |
| August 17, 2026 | 5.239B |
| August 14, 2026 | 5.414B |
| August 13, 2026 | 5.377B |
| August 12, 2026 | 5.568B |
| August 11, 2026 | 5.310B |
| August 10, 2026 | 5.231B |
| August 07, 2026 | 5.259B |
| August 06, 2026 | 4.928B |
| August 05, 2026 | 4.967B |
| August 04, 2026 | 5.088B |
| August 03, 2026 | 5.119B |
| July 31, 2026 | 4.824B |
| July 30, 2026 | 4.850B |
| July 29, 2026 | 4.922B |
| July 28, 2026 | 4.709B |
| July 27, 2026 | 4.717B |
| July 24, 2026 | 4.481B |
| July 23, 2026 | 4.341B |
| July 22, 2026 | 4.341B |
| July 21, 2026 | 4.445B |
| Date | Value |
|---|---|
| July 20, 2026 | 4.506B |
| July 17, 2026 | 4.509B |
| July 16, 2026 | 4.214B |
| July 15, 2026 | 4.085B |
| July 14, 2026 | 3.979B |
| July 13, 2026 | 4.276B |
| July 10, 2026 | 4.049B |
| July 09, 2026 | 3.981B |
| July 08, 2026 | 3.973B |
| July 07, 2026 | 4.071B |
| July 06, 2026 | 4.049B |
| July 02, 2026 | 4.133B |
| July 01, 2026 | 4.021B |
| June 30, 2026 | 3.953B |
| June 29, 2026 | 3.934B |
| June 26, 2026 | 3.754B |
| June 25, 2026 | 3.748B |
| June 24, 2026 | 3.723B |
| June 23, 2026 | 3.613B |
| June 22, 2026 | 3.748B |
| June 18, 2026 | 3.903B |
| June 17, 2026 | 3.734B |
| June 16, 2026 | 3.883B |
| June 15, 2026 | 3.967B |
| June 12, 2026 | 4.012B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 229.54B |
| Boston Scientific Corp. | 83.12B |
| DexCom, Inc. | 33.82B |
| Globus Medical, Inc. | 10.80B |
| Intuitive Surgical, Inc. | 127.09B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -183.00M |
| Revenue (Quarterly) | 837.00M |
| Total Expenses (Quarterly) | 1.02B |
| EPS Diluted (Quarterly) | -0.6517 |
| Gross Profit Margin (Quarterly) | 57.59% |
| Profit Margin (Quarterly) | -21.86% |
| Earnings Yield | -8.99% |
| Operating Earnings Yield | 7.89% |
| Normalized Earnings Yield | -1.188 |